These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36299835)

  • 1. Paxlovid with Caution: Novel Case of Paxlovid-Induced Tacrolimus Toxicity in a Cardiac Transplant Patient.
    Shah A; Nasrullah A; Butt MA; Young M
    Eur J Case Rep Intern Med; 2022; 9(9):003528. PubMed ID: 36299835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paxlovid (Nirmatrelvir/Ritonavir)-Induced Tacrolimus Toxicity in Organ Transplant Recipients - A Review on Drug Interactions Involving CYP3A Enzymes.
    Maideen NMP; Al Rashid S
    Curr Drug Saf; 2024 Sep; ():. PubMed ID: 39234905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: tacrolimus toxicity in the setting of concurrent Paxlovid use in a heart-transplant recipient.
    Modi S; Kahwash R; Kissling K
    Eur Heart J Case Rep; 2023 May; 7(5):ytad193. PubMed ID: 37252201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated tacrolimus levels after treatment with nirmatrelvir/ritonavir (Paxlovid) for COVID-19 infection in a child with a kidney transplant.
    Young C; Papiro T; Greenberg JH
    Pediatr Nephrol; 2023 Apr; 38(4):1387-1388. PubMed ID: 35982345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenytoin enzyme induction for management of supratherapeutic tacrolimus levels due to drug-drug interaction with nirmatrelvir/ritonavir: Case series and discussion.
    Marsh J; Logan AT; Bilgili EP; Bowman LJ; Webb AR
    Am J Health Syst Pharm; 2024 Jun; 81(13):e345-e352. PubMed ID: 38347740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paxlovid (Nirmatelvir/Ritonavir) and Tacrolimus Drug-Drug Interaction in a Kidney Transplant Patient with SARS-2-CoV infection: A Case Report.
    Prikis M; Cameron A
    Transplant Proc; 2022; 54(6):1557-1560. PubMed ID: 35599203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: Supratherapeutic tacrolimus concentrations with nirmatrelvir/ritonavir in a lung transplant patient: a case report using Rifampin for reversal.
    Xiong Y; Wang X; Li S; Zhang Q; Guo L; Chen W; Zhao Z; Liu L
    Front Pharmacol; 2023; 14():1285078. PubMed ID: 38026995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin.
    Sindelar M; McCabe D; Carroll E
    J Med Toxicol; 2023 Jan; 19(1):45-48. PubMed ID: 36536192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus toxicity due to enzyme inhibition from ritonavir.
    Snee I; Drobina J; Mazer-Amirshahi M
    Am J Emerg Med; 2023 Jul; 69():218.e5-218.e7. PubMed ID: 37173153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring tacrolimus toxicity following Paxlovid administration in a liver transplant patient.
    Maynard RD; Bates P; Korpi-Steiner N
    Pract Lab Med; 2023 Aug; 36():e00322. PubMed ID: 37649541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nirmatrelvir/ritonavir treatment in SARS-CoV-2 positive kidney transplant recipients - a case series with four patients.
    Schneider J; Wobser R; Kühn W; Wagner D; Tanriver Y; Walz G
    BMC Nephrol; 2023 Apr; 24(1):99. PubMed ID: 37061677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nirmatrelvir/ritonavir Use With Tacrolimus in Lung Transplant Recipients: A Single-center Case Series.
    Dewey KW; Yen B; Lazo J; Seijo L; Jariwala R; Shah RJ; Quan D; Carpenter B; Paul Singer J; Breen K; Hays S; Florez R
    Transplantation; 2023 May; 107(5):1200-1205. PubMed ID: 36525555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Saving lives with nirmatrelvir/ritonavir one transplant patient at a time".
    Belden KA; Yeager S; Schulte J; Cantarin MPM; Moss S; Royer T; Coppock D
    Transpl Infect Dis; 2023 Apr; 25(2):e14037. PubMed ID: 36847419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Interaction Between Tacrolimus and Paxlovid (Nirmatrelvir/Ritonavir) in an Adolescent with Inflammatory Bowel Disease.
    Zaarur L; Patel A; Pasternak B
    JPGN Rep; 2023 Nov; 4(4):e352. PubMed ID: 38034448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supratherapeutic Tacrolimus Concentrations With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients Requiring Hospitalization: A Case Series Using Rifampin for Reversal.
    Rose DT; Gandhi SM; Bedard RA; Mondy KE; Chu AL; Gamble KC; Gee AT; Kundra MA; Williams AL; Lee BK
    Open Forum Infect Dis; 2022 Jul; 9(7):ofac238. PubMed ID: 35854994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paxlovid-tacrolimus drug-drug interaction caused severe diarrhea that induced combined diabetic ketoacidosis and a hyperglycemic hyperosmolar state in a kidney transplant patient: a case report.
    Luo W; He Y; Wei MG; Lu GB; Yi Q
    J Med Case Rep; 2023 Sep; 17(1):406. PubMed ID: 37742028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient.
    Kwon EJ; Yun GA; Park S; Kim S; Chae DW; Park HS; Lee T; Jeong JC
    Kidney Res Clin Pract; 2022 Nov; 41(6):768-770. PubMed ID: 36474331
    [No Abstract]   [Full Text] [Related]  

  • 18. A case report of a prolonged decrease in tacrolimus clearance due to co-administration of nirmatrelvir/ritonavir in a lung transplant recipient receiving itraconazole prophylaxis.
    Tsuzawa A; Katada Y; Umemura K; Sugimoto M; Nishikawa A; Sato YK; Yoshida Y; Kitada N; Yonezawa A; Nakajima D; Date H; Terada T
    J Pharm Health Care Sci; 2023 Apr; 9(1):12. PubMed ID: 37004119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case report of drug interaction between co-packaged nirmatrelvir-ritonavir and tacrolimus causing hyponatremia in a lung transplant recipient.
    Lo CM; Chen WH; Tsai MY; Lu HI; Hsiao YH; Chuang KH; Chen Y; Wu HF; Huang KT; Wang YH
    J Cardiothorac Surg; 2024 Mar; 19(1):132. PubMed ID: 38491538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report: Paralytic ileus resulted from nirmatrelvir/ritonavir-tacrolimus drug-drug interaction in a systemic lupus erythematosus patient with COVID-19.
    Zhang W; Zhang X; Han J; Zhang W; Xu J; Zhang X; Bian H; Meng C; Shang D; Zhou Y; Wang D; Feng B
    Front Pharmacol; 2024; 15():1389187. PubMed ID: 38601471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.